Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors

• Sandra Martínez-Canales ,

  Contributed equally to this work with: Sandra Martínez-Canales, Francisco Cifuentes

  Affiliation Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain

  ⨯
• Francisco Cifuentes ,

  Contributed equally to this work with: Sandra Martínez-Canales, Francisco Cifuentes

  Affiliation Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain

  ⨯
• Miguel López De Rodas Gregorio,

  Affiliation Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain

  ⨯
• Leticia Serrano-Oviedo,

  Affiliation Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain

  ⨯
• Eva María Galán-Moya,

  Affiliation Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain

  ⨯
• Eitan Amir,

  Affiliation Princess Margaret Cancer Center, University of Toronto, Toronto, Canada

  ⨯
• Atanasio Pandiella,

  Affiliation Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain

  ⨯
• Balázs Győrffy,

  Affiliations MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary, Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary

  ⨯
• Alberto Ocaña

  * E-mail: albertoo@sescam.jccm.es

  Affiliations Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain, Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain

  ⨯